Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


SpaceX IPO Demand Surges Past $250 Billion Ahead of Historic Market Debut
Hanmi Semicon Shares Surge After $33 Million SpaceX Investment
Gold Prices Slide Toward Second Weekly Loss as Fed Rate Hike Expectations Weigh on Market
Meta Partners With Reliance to Launch First AI-Powered Data Center in India
European Stocks Rise Ahead of ECB Rate Decision as Investors Buy the Dip
SK Hynix Stock Rebounds as AI Memory Chip Demand Fuels Expansion Plans
GM and Peak Energy Partner to Advance Sodium-Ion Battery Technology for Grid Storage
Wizz Air Beats Profit Forecast as Cost Controls Offset Industry Challenges
Apple Unveils Enhanced Apple Intelligence and Next-Generation Siri at WWDC 2026
Alibaba Offers $1.5 Billion to Acquire Grocery Delivery Platform Pupu
Asian Currencies Mixed as Dollar Slips on Iran Peace Hopes and Fed Rate Outlook
Astera Labs and Rocket Lab Surge After Nasdaq-100 Inclusion Announcement
China Inflation Misses Forecast as Consumer Spending Stays Weak, Producer Prices Surge
Asian Stocks Rally as Trump Signals Iran Peace Deal; Tech and Chip Shares Rebound Strongly
Honda Leadership Crisis Deepens as Retired Executives Challenge CEO Toshihiro Mibe’s Strategy
US Dollar Edges Higher as Inflation Data and Middle East Tensions Shape Market Sentiment
Adobe Beats Q2 2026 Estimates, Raises Full-Year Outlook as AI Revenue Surges Despite Stock Drop 



